Back
BioXcel Therapeutics Stock Price Chart
Here's the Best Day to Buy Nvidia
Click here to see the green days for 5 major stocks today.
Sell
19
BTAI
BioXcel Therapeutics
Last Price:
$1.52
Seasonality Move:
-27.12%
7 Day Trial
ALL ACCESS PASS
$
7
Economic Policy Shifts = Huge Market Opportunity
See which of your stocks make the grade - analyze 3 stocks FREE.-
The current trend is relatively stagnant and BTAI is experiencing slight selling pressure.
BioXcel Therapeutics Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 1.31 | Buy |
| 20-day SMA: | 1.41 | Sell |
| 50-day SMA: | 1.68 | Sell |
| 200-day SMA: | 5.73 | Sell |
| 8-day EMA: | 1.33 | Buy |
| 20-day EMA: | 1.43 | Sell |
| 50-day EMA: | 1.83 | Sell |
| 200-day EMA: | 10.74 | Sell |
BioXcel Therapeutics Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.13 | Sell |
| Relative Strength Index (14 RSI): | 42.32 | Sell |
| Chaikin Money Flow: | -17409 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (1.3 - 1.68) | Sell |
| Bollinger Bands (100): | (1.17 - 4.13) | Sell |
BioXcel Therapeutics Technical Analysis
| May 20 | May 21 | May 22 | May 23 | May 27 | May 28 | May 29 | May 30 | Jun 2 | Jun 3 | |
|---|---|---|---|---|---|---|---|---|---|---|
| May | Jun | |||||||||
| 20 | 21 | 22 | 23 | 27 | 28 | 29 | 30 | 02 | 03 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for BioXcel Therapeutics Stock
Is BioXcel Therapeutics Stock a Buy?
-
BioXcel Therapeutics share price is 1.37 while BTAI 8-day simple moving average is 1.31, which is a Buy signal.
-
The stock price of BTAI is 1.37 while BioXcel Therapeutics 20-day SMA is 1.41, which makes it a Sell.
-
BioXcel Therapeutics 50-day simple moving average is 1.68 while BTAI share price is 1.37, making it a Sell technically.
-
BTAI stock price is 1.37 and BioXcel Therapeutics 200-day simple moving average is 5.73, creating a Sell signal.
BTAI Technical Analysis vs Fundamental Analysis
Sell
19
BioXcel Therapeutics (BTAI)
is a Sell
Is BioXcel Therapeutics a Buy or a Sell?
-
BioXcel Therapeutics stock is rated a SellThe current BioXcel Therapeutics [BTAI] share price is $1.37. The Score for BTAI is 19, which is 62% below its historic median score of 50, and infers higher risk than normal.
BioXcel Therapeutics Stock Info
Market Cap:
8.3M
Price in USD:
1.37
Share Volume:
226.3K
BioXcel Therapeutics 52-Week Range
52-Week High:
27.20
52-Week Low:
1.17
Sell
19
BioXcel Therapeutics (BTAI)
is a Sell
BioXcel Therapeutics Share Price Forecast
-
What is the BioXcel Therapeutics stock price today?The BioXcel Therapeutics stock price is 1.37 USD today.
-
Will BTAI stock go up or go down?BioXcel Therapeutics> share price is forecast to RISE/FALL based on technical indicators
-
Is BioXcel Therapeutics overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, BioXcel Therapeutics is overvalued.
Is BioXcel Therapeutics Stock a Buy?
-
BioXcel Therapeutics share price is 1.37 while BTAI 8-day exponential moving average is 1.33, which is a Buy signal.
-
The stock price of BTAI is 1.37 while BioXcel Therapeutics 20-day EMA is 1.43, which makes it a Sell.
-
BioXcel Therapeutics 50-day exponential moving average is 1.83 while BTAI share price is 1.37, making it a Sell technically.
-
BTAI stock price is 1.37 and BioXcel Therapeutics 200-day simple moving average is 10.74, creating a Sell signal.
Fundamental Analysis of BioXcel Therapeutics
Is BioXcel Therapeutics a good investment?
-
Analysts estimate an earnings increase this quarter of $5.84 per share, a decrease next quarter of $0.00 per share, an increase this year of $16.16 per share, and a decrease next year of $0.77 per share.
Technical Analysis of BioXcel Therapeutics
Should I short BioXcel Therapeutics stock?
-
BTAI Moving Average Covergence Divergence (MACD) indicator is -0.13, suggesting BioXcel Therapeutics is a Sell
-
BioXcel Therapeutics Relative Strength Index (RSI) is 42.32, which suggest BioXcel Therapeutics is oversold
-
The Bollinger Bands (25) for BioXcel Therapeutics is (1.3 - 1.68), which suggest BioXcel Therapeutics is a Sell
-
The Bollinger Bands (100) for BioXcel Therapeutics is (1.17 - 4.13), which suggest BioXcel Therapeutics is a Sell
* BioXcel Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.